Bicara Therapeutics Inc (BCAX)

04:53 AM

Is Bicara Therapeutics Inc. stock resilient to inflationJuly 2025 Earnings & AI Enhanced Market Trend Forecasts - newser.com

04:53 AM

09:09 AM

How Investors May Respond To Bicara Therapeutics (BCAX) FDA Breakthrough Therapy Nod for Lead Immunotherapy - Yahoo Finance

09:09 AM

08:12 AM

Bicara stock gains as H.C. Wainwright reiterates Buy rating on FDA breakthrough By Investing.com - Investing.com Australia

08:12 AM

07:51 AM

Bicara stock gains as H.C. Wainwright reiterates Buy rating on FDA breakthrough - Investing.com UK

07:51 AM

06:20 AM

Will Bicara Therapeutics Inc. stock see insider buyingJuly 2025 Momentum & Risk Adjusted Swing Trade Ideas - newser.com

06:20 AM

02:22 AM

Why Bicara Therapeutics Inc. stock is considered a top pick2025 Stock Rankings & Technical Pattern Based Signals - newser.com

02:22 AM

02:08 AM

Can Bicara Therapeutics Inc. recover in the next quarter2025 Buyback Activity & AI Enhanced Trading Alerts - newser.com

02:08 AM

Oct 13, 2025

Key facts: Merck reports $63.62B revenue; Bicara gains FDA breakthrough - TradingView

Oct 13, 2025

Oct 13, 2025

Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC - MarketScreener

Oct 13, 2025

Oct 13, 2025

Is Bicara Therapeutics Inc. stock a buy before product launchesJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - newser.com

Oct 13, 2025

Oct 13, 2025

Using Python tools to backtest Bicara Therapeutics Inc. strategies2025 Winners & Losers & Comprehensive Market Scan Insights - newser.com

Oct 13, 2025

Oct 13, 2025

Bicara stock jumps after FDA grants breakthrough therapy status By Investing.com - Investing.com Nigeria

Oct 13, 2025

Oct 13, 2025

Bicara stock jumps after FDA grants breakthrough therapy status - Investing.com

Oct 13, 2025

Oct 13, 2025

Bicara Therapeutics Says Potential Head, Neck Cancer Drug Gets FDA Breakthrough Therapy Designation - MarketScreener

Oct 13, 2025

Oct 13, 2025

Bicara Therapeutics climbs after FDA's 'breakthrough' tag for cancer therapy - TradingView

Oct 13, 2025

Oct 13, 2025

Bicara Therapeutics Inc. stock chart pattern explainedWeekly Stock Report & High Accuracy Trade Alerts - newser.com

Oct 13, 2025

Oct 13, 2025

Why Bicara Therapeutics Is Rising In Pre-market? - Nasdaq

Oct 13, 2025

Oct 13, 2025

FDA grants breakthrough therapy status to Bicara’s cancer drug - Investing.com

Oct 13, 2025

Oct 13, 2025

Bicara Therapeutics Announces Ficerafusp Alfa Granted - GlobeNewswire

Oct 13, 2025

Oct 12, 2025

How to build a custom watchlist for Bicara Therapeutics Inc.Weekly Trade Recap & Intraday High Probability Alerts - newser.com

Oct 12, 2025

Oct 11, 2025

Ivan Hyep Sells 6,415 Shares of Bicara Therapeutics (NASDAQ:BCAX) Stock - MarketBeat

Oct 11, 2025

Oct 11, 2025

Bicara Therapeutics (NASDAQ:BCAX) Insider David Raben Sells 22,000 Shares - MarketBeat

Oct 11, 2025

Oct 11, 2025

Hyep Ivan, CFO of Bicara Therapeutics, sells $116k in shares By Investing.com - Investing.com Australia

Oct 11, 2025

Oct 11, 2025

Hyep Ivan, CFO of Bicara Therapeutics, sells $116k in shares - Investing.com Canada

Oct 11, 2025

Oct 09, 2025

Bicara Therapeutics (NASDAQ:BCAX) CFO Ivan Hyep Sells 18,244 Shares - MarketBeat

Oct 09, 2025

Oct 09, 2025

Bicara Therapeutics (NASDAQ:BCAX) COO Sells $715,176.00 in Stock - MarketBeat

Oct 09, 2025

Oct 09, 2025

Bicara Therapeutics (NASDAQ:BCAX) COO Ryan Cohlhepp Sells 10,900 Shares - MarketBeat

Oct 09, 2025

Oct 09, 2025

Ivan Hyep Sells 6,514 Shares of Bicara Therapeutics (NASDAQ:BCAX) Stock - MarketBeat

Oct 09, 2025

Oct 09, 2025

Insider Selling: Bicara Therapeutics (NASDAQ:BCAX) CFO Sells 5,627 Shares of Stock - MarketBeat

Oct 09, 2025

Oct 09, 2025

Risk adjusted return profile for Bicara Therapeutics Inc. analyzedJuly 2025 Selloffs & Breakout Confirmation Trade Signals - newser.com

Oct 09, 2025

Oct 09, 2025

Can Bicara Therapeutics Inc. stock resist sector downturnsWeekly Stock Report & Risk Managed Investment Strategies - newser.com

Oct 09, 2025

Oct 09, 2025

Bicara Therapeutics CFO Hyep Ivan sells $553,198 in shares By Investing.com - Investing.com Canada

Oct 09, 2025

Oct 08, 2025

Bicara therapeutics president Cohlhepp sells $911k in shares - Investing.com

Oct 08, 2025

Oct 08, 2025

Bicara Therapeutics CFO Hyep Ivan sells $553,198 in shares - Investing.com

Oct 08, 2025

Oct 08, 2025

Bicara therapeutics president Cohlhepp sells $911k in shares By Investing.com - Investing.com UK

Oct 08, 2025

Oct 07, 2025

Day 8 of Gains Streak for Bicara Therapeutics Stock with 70% Return (vs. 4.3% YTD) [10/7/2025] - Trefis

Oct 07, 2025

Oct 07, 2025

4 Biotech Stocks Seeing Explosive Momentum GainsAldeyra Therapeutics (NASDAQ:ALDX) - Benzinga

Oct 07, 2025

Oct 06, 2025

Statistical indicators supporting Bicara Therapeutics Inc.’s strengthGlobal Markets & Expert Curated Trade Setup Alerts - newser.com

Oct 06, 2025

Oct 06, 2025

What drives Bicara Therapeutics Inc stock priceVWAP Trading Strategies & Free Tremendous Portfolio Expansion - earlytimes.in

Oct 06, 2025

Oct 05, 2025

Is Bicara Therapeutics Inc. stock reversal real or fakeJuly 2025 Trade Ideas & AI Powered Market Entry Ideas - newser.com

Oct 05, 2025

Oct 05, 2025

Key metrics from Bicara Therapeutics Inc.’s quarterly dataQuarterly Portfolio Summary & Weekly High Potential Alerts - newser.com

Oct 05, 2025

Oct 03, 2025

Bicara Therapeutics Files $400 Million Mixed Shelf - MarketScreener

Oct 03, 2025

Oct 03, 2025

Bicara Therapeutics files for mixed shelf offering of up to $400 millionSEC filing - MarketScreener

Oct 03, 2025

Oct 03, 2025

How to read the order book for Bicara Therapeutics Inc.Fed Meeting & Real-Time Sentiment Analysis - newser.com

Oct 03, 2025

Oct 01, 2025

Bicara reports positive Phase 1/1b trial results for cancer therapy - MSN

Oct 01, 2025

Sep 30, 2025

Stifel maintains Buy on Bicara stock with $47 target - MSN

Sep 30, 2025